CNN has a reasonably decent article on the controversial advertising campaign by Eli Lily pushing their medication for treatment of "Adult ADD"., entitled "Adult ADD: Common disorder or marketing ploy?" As one doctor is quoted:
some ethicists said the ad campaigns, paired with education programs for physicians, may result in people receiving drugs who don't really need them.
"I am worried that what you're going to do is generate a disease rather than respond to a problem," said Art Caplan, a bioethicist at the University of Pennsylvania.
Some experts said they find at least parts of the screening tool too broad, with questions such as, "How often do you have difficulty waiting your turn in situations when turn taking is required," asking respondents to choose never, rarely, sometimes, often or very often.
"I've yet to meet the person who says, 'Oh, I really love waiting in line. The longer the line the better,' " said Dr. Edward Hallowell, a psychiatrist and author of the best-seller "Driven to Distraction: Recognizing and Coping With Attention Deficit Disorder From Childhood Through Adulthood."
Caplan said, "Trying to hook a potential user of your drug by this type of questionnaire technique just strikes me as ethically suspicious."
ethically suspicious?
Of course, CNN tries to be fair to both sides, which tends to gloss over this 'minor' detail.
Friday, July 18, 2003
Adult ADD: Common disorder or marketing ploy?
Labels:
ADHD/ADD,
disease mongering,
drug companies,
marketing,
USA
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment